On Friday, May 15th, Dr. Stephen Scoper lectured to Orlando ophthalmologists about exciting new technology concerning premium IOLs for patients undergoing cataract surgery. The lecture, hosted at Ruth's Chris Steakhouse in Orlando, Florida, focused on the advancements brought forth by the new ReSTOR® Aspheric +3 add intraocular lens. This lens was FDA-approved in January 2009.
Dr. Scoper presented his first lecture on the ReSTOR® +3 IOL at the New Orleans Academy of Ophthalmology on the first weekend of February, 2009. The ReSTOR® +3 IOL had been available in the United States for only 2 weeks at the time of Dr. Scoper's lecture.
As compared to the original ReSTOR® +4 add IOL, the +3 IOL has a focal point at 16-20 inches which is a more comfortable working distance for most patients. The ReSTOR® +4 IOL has a working distance of about 12 inches. The new +3 IOL also improves intermediate vision allowing "arms length" vision of the computer screen.
Dr. Scoper reviewed the binocular defocus curve (shown, left) which demonstrated the scientifically-proven effectiveness of the ReSTOR® +3 IOL, providing for a much greater range of vision for patients who participated in clinical trials.
(For a larger, detailed view of the binocular defocus curve, click the image above. View related slides by clicking the pictures below.)
Additionally, Dr. Scoper discussed the newly FDA-approved AcrySof® IQ TORIC to correct astigmatism at the time of cataract surgery. This lens now has the aspheric surface desired to correct positive spherical aberrations– reducing glare and halos while increasing contrast sensitivity for patients. This aspheric technology has been available on the ReSTOR® multi-focal IOL for over two years and has recently been approved for the AcrySof® TORIC IOL.
No comments:
Post a Comment